November 14th, 2008 Posted in News | No Comments »
The University of California, San Francisco (UCSF) Children’s Hospital has opened an innovative new clinical unit focusing on the infant brain that is the first facility of its kind in the United States. The unit brings together specialized treatment and clinical research for infants who show signs of brain damage at birth and are at-risk for developing cerebral palsy, mental retardation and other cognitive disorders. The facility, named the Neuro-Intensive Care Nursery (NICN) will also host clinical trials and bring the latest cutting-edge treatments to patients.
“My hope is that by bringing scientists and clinicians together in the NICN we will be able to establish the root causes of brain damage in infants so that we can offer patients and their families real therapeutic options,” said David Rowitch, director of the NICN. “Our highly skilled team of experts is well-equipped to address the critical need for improved care of the infant brain,” said Sam Hawgood, MB, BS, chair of the UCSF Department of Pediatrics. “By offering the most advanced treatments and hosting clinical trials, the new NICN is positioned to have a tremendous impact on care today and for years to come.”
One treatment now used by the NICN team is hypothermia, which involves cooling a newborn’s brain and body by a few degrees immediately after birth. Research has shown that hypothermia treatment within the first six hours of an infant’s life can help prevent or minimize the long-term consequences of brain damage caused by a loss of oxygen during birth. Hypothermia treatments, however, have only been tested in full-term infants.
Another key component of the new NICN is the use of an advanced neonatal brain monitoring system, called cerebral function monitoring or amplitude integrated electroencephalography (aEEG), which provides a window into the brain activity of newborns. “By monitoring the electrical function of the newborn brain under various conditions of illness and stress, we will gain a better understanding of how our treatments affect brain function and the risk of injury. This, in turn, will lead to better treatments to optimize neurological outcome,” said Yao Sun, MD, PhD, director of neonatal clinical programs at UCSF.
If you would like to learn more about UCSF Children’s Hospital and the treatments it offers, please click here.
Also for the full article, please click here.